First Time Loading...

Advanced Medical Solutions Group PLC
LSE:AMS

Watchlist Manager
Advanced Medical Solutions Group PLC Logo
Advanced Medical Solutions Group PLC
LSE:AMS
Watchlist
Price: 185.8 GBX -0.43% Market Closed
Updated: Apr 28, 2024
Section:
 

Relative Value

The Relative Value of one AMS stock under the Base Case scenario is 352.57 GBX. Compared to the current market price of 185.8 GBX, Advanced Medical Solutions Group PLC is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMS Relative Value
Base Case
352.57 GBX
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
98
vs Industry
38
Median 3Y
5.1
Median 5Y
5.3
Industry
2.4
Forward
2.6
More Details
25.4
P/E
P/E
Price to Earnings
25.4
vs History
85
vs Industry
23
Median 3Y
32.7
Median 5Y
31.2
Industry
23.2
Forward
17.6
More Details
32.7
P/OCF
P/OCF
Price to OCF
32.7
vs History
9
vs Industry
12
Median 3Y
22.8
Median 5Y
24
Industry
15.5
More Details
1 483.8
P/FCFE
P/FCFE
Price to FCFE
1 483.8
vs History
6
vs Industry
0
Median 3Y
35.7
Median 5Y
37.2
Industry
23.5
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
98
vs Industry
49
Median 3Y
2.4
Median 5Y
2.7
Industry
2.2
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
98
vs Industry
40
Median 3Y
4.5
Median 5Y
4.7
Industry
2.5
Forward
2.2
More Details
5
EV/GP
EV/GP
Enterprise Value to Gross Profit
5
vs History
96
vs Industry
44
Median 3Y
7.9
Median 5Y
7.9
Industry
5.2
More Details
11.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.9
vs History
93
vs Industry
29
Median 3Y
16
Median 5Y
16.8
Industry
12.5
Forward
9.1
More Details
18.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.6
vs History
79
vs Industry
25
Median 3Y
21.9
Median 5Y
21.5
Industry
17.2
Forward
11.9
More Details
28.5
EV/OCF
EV/OCF
Enterprise Value to OCF
28.5
vs History
12
vs Industry
14
Median 3Y
20.7
Median 5Y
21.3
Industry
15.1
More Details
140.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
140.9
vs History
6
vs Industry
3
Median 3Y
27.6
Median 5Y
29.6
Industry
19.7
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
98
vs Industry
43
Median 3Y
2.8
Median 5Y
3.1
Industry
2
More Details

Multiples Across Competitors

AMS Competitors Multiples
Advanced Medical Solutions Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Advanced Medical Solutions Group PLC
LSE:AMS
403.8m GBP 3.2 25.4 11.9 18.6
JP
Hoya Corp
TSE:7741
6.4T JPY 8.6 38.5 23.4 28.9
CH
Alcon AG
SIX:ALC
35.5B CHF 4.1 39.9 17.8 36.2
DK
Coloplast A/S
CSE:COLO B
194.1B DKK 7.8 39.9 26.2 30.4
US
Align Technology Inc
NASDAQ:ALGN
23.2B USD 6 52.1 27.8 33.8
US
Cooper Companies Inc
NYSE:COO
17.7B USD 4.8 60.7 22.3 37.8
KR
HLB Inc
KOSDAQ:028300
14.3T KRW 333.3 -75.6 -123.3 -113.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
55.1B CNY 14 33.3 29 29
UK
ConvaTec Group PLC
LSE:CTEC
5.3B GBP 3.1 50.7 46.8 50.9
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
6.3B USD 1.6 -48 12.2 26.3
CA
Bausch + Lomb Corp
NYSE:BLCO
5.2B USD 1.3 -20 15.8 44.1

See Also

Summary
AMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMS stock valuation using valuation multiples.
Wall Street Estimates
AMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.